Nitazenes: Why California Rehab Centers Are Seeing a New Wave of Patients

In September 2025, a 22-year-old Stevenson Ranch, CA, man died after consuming what he thought was Xanax [1]. Instead, it was laced with nitazenes, a class of synthetic opioids up to 40 times more potent than fentanyl. Nitazenes have been detected in California’s drug supply, leading to other fatal overdoses in counties like Los Angeles, San Francisco, and Sacramento.

This isn’t just another dangerous drug; it’s a game-changer that is fundamentally altering the addiction landscape, although estimated at 2% of the drug supply [2]. 

Believing they are using heroin or counterfeit pills, many people are unknowingly exposed to nitazenes. As a result, they find themselves facing a dependency that is faster-acting and more severe than anything before.

In this article, I explore the special clinical challenges of nitazene addiction, from extreme withdrawal to naloxone resistance, that are driving a surge in patients seeking specialized, life-saving treatment at California rehab centers.

The Dangerous Threat of Nitazenes

There are many variants (analogues) of nitazenes. All are extremely potent, in some cases up to 40 times stronger than fentanyl. Some are 500-1,000 times more potent than morphine. A dose invisible to the naked eye can be lethal.

Most people don’t seek out nitazenes. Instead, they are used as an inexpensive adulterant in heroin, fentanyl, and counterfeit pills. This means users have no tolerance for the drug they are actually ingesting, leading to a spike in overdoses and rapid, unexpected addiction.

Unlike traditional opioids, nitazenes create a physical dependence at an alarming speed due to their high “receptor affinity” (how strongly they bind to opioid receptors in the brain). The body becomes reliant on the drug much faster.

What “40x Stronger Than Fentanyl” Refers To

Nitazenes (e.g., etonitazene, isotonitazene, and N‑desethyl isotonitazene) are lab‑designed opioids originally discovered in the late 1950s and early 1960s but never approved for clinical use since they were so potent. They re‑emerged in the illicit drug supply in 2019.

Research shows N‑desethyl isotonitazene can be ~31‑fold more potent than fentanyl at the mu‑opioid receptor, with other nitazenes several‑fold stronger than fentanyl and all much more potent than morphine [3]. As of 2025, over 30 other nitazene analogues have been identified [4]. 

The media summarize this range as “up to 40 times stronger than fentanyl,” and nitazenes are now widely described as 10–40x fentanyl’s potency.

​Why Standard Addiction Protocols Are Failing

There are a number of reasons why standard protocols are failing:

• Inadequate MAT Protocols: Standard doses of Medication-Assisted Treatment (MAT) drugs like buprenorphine or methadone, which work for heroin or even fentanyl, are often insufficient for nitazenes. The nitazene molecules occupy the brain’s receptors so strongly that standard MAT doses cannot displace them, leaving patients in withdrawal or at immediate risk of relapse.

• The Naloxone Challenge: A single dose of naloxone (Narcan) is often not enough to reverse a nitazene overdose. First responders and families are being forced to use multiple doses, and prolonged medical monitoring is required because the overdose can return as the naloxone wears off.

• Withdrawal Severity: Because the drug is so potent, the “rebound” effect is brutal. Withdrawal symptoms begin within hours, are intensely physical and psychological, and can lead to severe medical complications if not managed under 24/7 medical supervision

Clinical and Systems Implications for California Rehabs

Nitazenes are appearing mixed into heroin, fentanyl, and counterfeit pills, so people often do not know they are using them, which increases overdose risk and complicates history‑taking on admission.

Many hospital and community toxicology panels can detect fentanyl, but do not detect nitazenes. As a result, patients may present with severe opioid toxicity or withdrawal despite negative fentanyl screens, creating diagnostic uncertainty at intake.

California programs are beginning to market dedicated nitazene treatment capacity, emphasizing higher‑acuity medical detox, continuous monitoring, and tight coordination with hospital‑level services because of unpredictable withdrawal and respiratory depression.

Why Rehabs Are Seeing a “New Wave” of Patients

As enforcement and market dynamics shift, the non‑fentanyl novel synthetic opioid segment (including nitazenes) is expanding. Surveillance systems in North America and Europe have linked nitazenes to hundreds of overdose deaths since 2019, with indications of increasing detection in recent years.

A new wave of patients is showing up at California rehab centers. It includes long-time opioid users whose bodies no longer respond to standard treatment, but also a wave of individuals who unknowingly became addicted after taking what they thought were prescription medications 

California detox and residential centers report that people presenting for nitazene‑related use often arrive in profound physical depletion with repeated near‑fatal overdoses, requiring more intensive stabilization and closely structured programming than many standard opioid use disorder cases.

There is a devastating psychological toll with associated trauma. Many patients arrive at rehab centers having survived multiple overdoses or having witnessed friends die. This requires integrated psychiatric care to address PTSD and the terror of “near-death experiences”.

Raising Awareness

Public health alerts and media coverage around “even worse than fentanyl” opioids have raised awareness, which likely contributes both to higher referral rates and to more self‑initiated help‑seeking among people who fear imminent fatal overdose.​

Data show that the crisis is statewide, from news reports of fatal overdoses in major cities to the increase in calls to treatment centers. And this is not just an urban problem but is affecting communities across California.

How California Rehab Centers Are Adapting

Rehab centers are responding in several ways:

Aggressive Medical Intervention:  First‑line pharmacotherapy remains opioid agonist treatment (buprenorphine or methadone) plus naloxone distribution, but programs are adapting protocols (e.g., careful induction strategies, extended observation) because of extreme potency and uncertain pharmacokinetics. This includes using higher, more carefully calibrated doses of MAT medications that are under close monitoring to achieve “receptor blockade” and prevent immediate relapse.

Extended Monitoring and Detox: Unlike traditional detox, patients may require extended observation periods due to the unpredictable pharmacokinetics of nitazenes. Rehab centers are moving away from “one-size-fits-all” timelines to ensure patient safety. 

To help patients process the intense experiences associated with their use and build resilience for the future, rehab centers are using a multipronged approach to treatment. 

Holistic and Trauma-Informed Care: Treatment now goes beyond detox. Facilities are incorporating:

• Evidence‑based Cognitive Behavioral Therapy (CBT)
• Dialectical Behavior Therapy (DBT)
• Contingency Management
• Relapse‑prevention work
• Trauma-informed care
• Strong aftercare and overdose‑prevention planning are essential given ongoing exposure risk in the supply.

Why Choose Northbound Treatment Services?

At Northbound, we have extensive experience helping patients overcome their substance abuse addictions, including opioids, and we have a Christian faith-based track for those wishing to participate. 

We offer a wide range of evidence-based therapies, counseling, and trauma-informed support to help you heal. We personalize each treatment plan around the needs of our patients.

The first steps are detoxification and stabilization, under 24-hour medical supervision in our Withdrawal Management center for whatever time you may require. 

Our inpatient residential program offers 24/7 live-in treatment for substance abuse. Our outpatient treatment provides a flexible step-down from our residential program, allowing you to live at home and participate for several hours a day. 

For more than 30 years, Northbound Treatment Services in California has been at the forefront of providing lifesaving, compassionate residential care and specialized services to help people from all walks of life feel better, discover themselves, and live free from addiction. 

We have facilities located throughout California to help guide you on your recovery journey. Reach out to our admissions team now.

Sources

[1] Admin. 2025. Southern California 22-year-old dies from overdose on potent new opioid. Socalpress.com

[2] Dasgupta N. 2025. The Year in Drugs 2025. Opioiddata.org.

[3] Tsai, M. M., Chen, L., Baumann, M. H., Canals, M., Javitch, J. A., Lane, J. R., & Shi, L. (2023). The in vitro functional profiles of fentanyl and nitazene analogs at the μ-opioid receptor – high efficacy is dangerous regardless of signaling bias. bioRxiv : the preprint server for biology, 2023.11.10.

[4] Pereira, J. R. P., Quintas, A., & Neng, N. R. (2025). Nitazenes: The Emergence of a Potent Synthetic Opioid Threat. Molecules (Basel, Switzerland), 30(19), 3890.